New pharmacological treatment strategies for relapse prevention

Current Topics in Behavioral Neurosciences

Volumn 13, Issue , 2012, Pages 583-609

  Spanagel, Rainer ^a   Vengeliene, Valentina ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acetaldehyde dehydrogenase; Alcohol deprivation effect; Antabuse; Campral; Genomewide analysis; Hyper glutamatergic state; Kappa opioid receptors; Nalmefene; Revia; Vivitrol

Indexed keywords

ACAMPROSATE; ACETALDEHYDE; ALCOHOL DEHYDROGENASE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DISULFIRAM; DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE BETA MONOOXYGENASE; GHRELIN RECEPTOR; GHRELIN RECEPTOR ANTAGONIST; GLUTAMIC ACID; GLYCINE TRANSPORTER; GLYCINE TRANSPORTER ANTAGONIST; GUANINE NUCLEOTIDE EXCHANGE FACTOR; KAPPA OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALMEFENE; NALTREXONE; NERAMEXANE; NEUROKININ 1 RECEPTOR ANTAGONIST; NORADRENALIN; RAS PROTEIN; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; DRUG DERIVATIVE; DRUGS USED IN THE TREATMENT OF ADDICTION; NEW DRUG; TAURINE;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL (TOPIC); DRUG REPOSITIONING; DYSPNEA; FLUSHING; GENOME ANALYSIS; HANGOVER; HEADACHE; HUMAN; MENTAL DISEASE; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NAUSEA AND VOMITING; NEUROBIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PUNISHMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; SUBSTITUTION THERAPY; SYSTEMATIC REVIEW (TOPIC); TACHYCARDIA; VISUAL DISORDER; ANIMAL; CHEMISTRY; HISTORY; METABOLISM; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; REVIEW;

ALCOHOL DETERRENTS; ALCOHOL-RELATED DISORDERS; ANIMALS; DISULFIRAM; DRUGS, INVESTIGATIONAL; HISTORY, 18TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NALTREXONE; RECEPTORS, N-METHYL-D-ASPARTATE; RECURRENCE; TAURINE;

EID: 84868666534     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2012_205     Document Type: Article

References (128)

1. Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, Abenavoli L, D'Angelo C, Caputo F, Zambon A, Haber PS, Gasbarrini G (2007) Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370: 1915-1922
2. Adermark L, Clarke RB, Olsson T, Hansson E, Söderpalm B, Ericson M (2011) Implications for glycine receptors and astrocytes in ethanol-induced elevation of dopamine levels in the nucleus accumbens. Addict Biol 16: 43-54
3. Andronis C, Sharma A, Virvilis V, Deftereos S, Persidis A (2011) Literature mining, ontologies and information visualization for drug repurposing. Brief Bioinform 12: 357-368
4. Anton RF et al (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295: 2003-2017
5. Bachteler D, Spanagel R (2005) Glutamatergic compounds: a perspective. In Drugs for Relapse Prevention of Alcoholism, eds. R Spanagel, K Mann, Birkhäuser Basel: 205-217
6. Barr CS (2010) Commentary on Nelson et al. (2010). Addict Biol 15: 12-14
7. Bazov I, Kononenko O, Watanabe H, Kuntić V, Sarkisyan D, Taqi MM, Hussain MZ, Nyberg F, Yakovleva T, Bakalkin G (2011) The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction. Addict Biol [Epub ahead of print]
8. Bienkowski P, Koros E, Kostowski W, Danysz W (1999) Effects of N-methyl-D-aspartate receptor antagonists on reinforced and nonreinforced responding for ethanol in rats. Alcohol 18: 131-137
9. Bienkowski P, Krzascik P, Koros E, Kostowski W, Scinska A, Danysz W (2001) Effects of a novel uncompetitive NMDA receptor antagonist, MRZ 2/579 on ethanol self-administration and ethanol withdrawal seizures in the rat. Eur J Pharmacol 413: 81-89
10. Blednov YA, Walker D, Martinez M, Harris RA (2006) Reduced alcohol consumption in mice lacking preprodynorphin. Alcohol 40: 73-86
11. Blomeyer D, Treutlein J, Esser G, Schmidt MH, Schumann G, Laucht M (2008) Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biol Psychiatry 63: 146-151
12. Brager AJ, Prosser RA, Glass JD (2011a) Circadian and acamprosate modulation of elevated ethanol drinking in mPer2 clock gene mutant mice. Chronobiol Int 28: 664-672
13. Brager A, Prosser RA, Glass JD (2011b) Acamprosate-responsive brain sites for suppression of ethanol intake and preference. Am J Physiol Regul Integr Comp Physiol 301: R1032-R1043
14. Chamorro AJ, Marcos M, Mirón JA, Pastor I, González-Sarmiento R, FJ Laso (2011) Association of l-opioid Receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis. Addict Biol [Epub ahead of print]
15. Chatterton JE, Awobuluyi M, Premkumar LS, Takahashi H, Talantova M, Shin Y, Cui J, Tu S, Sevarino KA, Nakanishi N, Tong G, Lipton SA, Zhang D (2002) Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415: 793-798
16. Chefer V, Meis J, Wang G, Kuzmin A, Bakalkin G, Shippenberg T (2011) Repeated exposure to moderate doses of ethanol augments hippocampal glutamate neurotransmission by increasing release. Addict Biol 16: 229-237
17. Ciccocioppo R et al (2004) Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology (Berl) 172: 170-178
18. Cole JC, Littleton JM, Little HJ (2000) Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plusmaze. Psychopharmacology (Berl) 147: 403-411
19. Colombo G, Addolorato G, Agabio R, Carai MA, Pibiri F, Serra S, Vacca G, Gessa GL (2004) Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics. Neurotox Res 6: 403-414
20. D'Addario C, Caputi FF, Rimondini R, Gandolfi O, Del Borrello E, Candeletti S, Romualdi P (2011) Different alcohol exposures induce selective alterations on the expression of dynorphin and nociceptin systems related genes in rat brain. Addict Biol [Epub ahead of print]
21. Dahchour A, De Witte P (2003) Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods. Alcohol Clin Exp Res 27: 465-470
22. De Witte P, Pinto E, Ansseau M, Verbanck P (2003) Alcohol and withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev 27: 189-197
23. Diana M (2011) The dopamine hypothesis of drug addiction and its potential therapeutic value. Front Psychiatry 2: 64
24. Dole VP, Nyswander ME (1967) Rehabilitation of heroin addicts after blockade with methadone. N Y State J Med 66: 2011-2017
25. Domart MC, Benyamina A, Lemoine A, Bourgain C, Blecha L, Debuire B, Reynaud M, Saffroy R (2011) Association between a polymorphism in the promoter of a glutamate receptor subunit gene (GRIN2A) and alcoholism. Addict Biol [Epub ahead of print]
26. Edwards S, Kenna GA, Swift RM, Leggio L (2011) Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review. Curr Pharm Des 17: 1323-1332
27. Ehlers CL, Walter NA, Dick DM, Buck KJ, Crabbe JC (2010) A comparison of selected quantitative trait loci associated with alcohol use phenotypes in humans and mouse models. Addict Biol 15: 185-199
28. Fasano S, Brambilla R (2011) Ras-Erk signaling in behavior: old questions and new perspectives. Front Behav Neurosci 5: 79
29. Feeney GF et al (2006) Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy. Alcohol Alcohol 41: 321-327
30. Femenía T, Manzanares J (2012) Increased ethanol intake in prodynorphin knockout mice is associated to changes in opioid receptor function and dopamine transmission. Addict Biol 17: 322-337
31. Flory JD, Pytte CL, Hurd Y, Ferrell RE, Manuck SB (2011) Alcohol dependence, disinhibited behavior and variation in the prodynorphin gene. Biol Psychol 88: 51-56
32. Frank J, Cichon S, Treutlein J, Ridinger M, Mattheisen M, Hoffmann P, Herms S, Wodarz N, Soyka M, Zill P, Maier W, Mössner R, Gaebel W, Dahmen N, Scherbaum N, Schmäl C, Steffens M, Lucae S, Ising M, Müller-Myhsok B, Nöthen MM, Mann K, Kiefer F, Rietschel M (2012) Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol 17: 171-180
33. Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT (1999) Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 281: 1318-1325
34. Gass JT, Olive MF (2008) Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 75: 218-265
35. Gass JT, Sinclair CM, Cleva RM, Widholm JJ, Olive MF (2011) Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors. Addict Biol 16: 215-228
36. Gastfriend DR (2011) Intramuscular extended-release naltrexone: current evidence. Ann N Y Acad Sci 1216: 144-166
37. Gebicke-Haerter P (2005) Expression profiling methods used in drug abuse research. Addict Biol 10: 37-46
38. George DT, Gilman J, Hersh J, Thorsell A, Herion D, Geyer C, Peng X, Kielbasa W, Rawlings R, Brandt JE, Gehlert DR, Tauscher JT, Hunt SP, Hommer D, Heilig M (2008) Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science 319: 1536-1539
39. Goldman D, Oroszi G, Ducci F (2005) The genetics of addictions: uncovering the genes. Nat Rev Genet 6: 521-532
40. Goldstein M, Anagnoste B, Lauber E, McKeregham MR (1964) Inhibition of dopamine-betahydroxylase by disulfiram. Life Sci 3: 763-767
41. Hald J, Jacobsen E (1948) A drug sensitizing the organism to ethyl alcohol. Lancet 2: 1001-1004
42. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Björk K, Soverchia L, Terasmaa A, Massi M, Heilig M, Ciccocioppo R (2006) Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A 103: 15236-15241
43. Heidbreder CA, Gardner EL, Xi ZX, Thanos PK, Mugnaini M, Hagan JJ, Ashby CR Jr (2005) The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev 49: 77-105
44. Heilig M (2011) Our focus on the pharmacogenetics of CRF(1) antagonists is simply because they are in clinical development. Nat Rev Neurosci 13: 70
45. Heilig M, Koob GF (2007) A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30: 399-406
46. Heilig M, Thorsell A, Sommer WH, Hansson AC, Ramchandani VA, George DT, Hommer D, Barr CS (2010a) Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev 35: 334-344
47. Heilig M, Egli M, Crabbe JC, Becker HC (2010b) Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addict Biol 15: 169-184
48. Heilig M, Goldman D, Berrettini W, O'Brien CP (2011) Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci 12: 670-684
49. Hermann D, Weber-Fahr W, Sartorius A, Hoerst M, Frischknecht U, Tunc-Skarka N, Perreau-Lenz S, Hansson AC, Krumm B, Kiefer F, Spanagel R, Mann K, Ende G, Sommer WH (2011) Translational Magnetic Resonance Spectroscopy Reveals Excessive Central Glutamate Levels During Alcohol Withdrawal in Humans and Rats. Biol Psychiatry [Epub ahead of print]
50. Hölter SM, Danysz W, Spanagel R (1996) Evidence for alcohol anti-craving properties of memantine. Eur J Pharmacol 314: R1-R2
51. Hölter SM, Danysz W, Spanagel R (2000) Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure. J Pharmacol Exp Ther 292: 545-552
52. Hundt W, Danysz W, Holter SM, Spanagel R (1998) Ethanol and N-methyl-D-aspartate receptor complex interactions: a detailed drug discrimination study in the rat. Psychopharmacology 135: 44-51
53. Jerlhag E, Egecioglu E, Landgren S, Salomé N, Heilig M, Moechars D, Datta R, Perrissoud D, Dickson SL, Engel JA (2009) Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci U S A 106: 11318-11323
54. Jerlhag E, Egecioglu E, Dickson SL, Engel JA (2011) Glutamatergic regulation of ghrelininduced activation of the mesolimbic dopamine system. Addict Biol 16: 82-91
55. Kaiser J (2010) National Institutes of Health. Collins endorses merger of U. S. addiction research programs. Science 330: 1166
56. Karpyak VM, Geske JR, Colby CL, Mrazek DA, Biernacka JM (2011) Genetic variability in the NMDA-dependent AMPA trafficking cascade is associated with alcohol dependence. Addict Biol [Epub ahead of print]
57. Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R (2007) Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study. Alcohol Clin Exp Res 31: 1179-1187
58. Kiefer F et al (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60: 92-99
59. Kiefer F, Spanagel R (2006) Measuring alcohol consumption in man-it is time for a change. Addiction 101: 1215-1216
60. Kiefer F, Witt SH, Frank J, Richter A, Treutlein J, Lemenager T, Nöthen MM, Cichon S, Batra A, Berner M, Wodarz N, Zimmermann US, Spanagel R, Wiedemann K, Smolka MN, Heinz A, Rietschel M, Mann K (2011) Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate. Pharmacogenomics J 11: 368-374
61. Kotlinska J, Biala G, Rafalski P, Bochenski M, Danysz W (2004) Effect of neramexane on ethanol dependence and reinforcement. Eur J Pharmacol 503: 95-98
62. Kotlinska J, Bochenski M, Danysz W (2006) N-methyl-D-aspartate and group I metabotropic glutamate receptors are involved in the expression of ethanol-induced sensitization in mice. Behav Pharmacol. 17: 1-8
63. Kovacs KM, Szakall I, O'Brien D, Wang R, Vinod KY, Saito M, Simonin F, Kieffer BL, Vadasz C (2005) Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol Clin Exp Res 29: 730-738
64. Krystal JH, Petrakis IL, Mason G, Trevisan L, D'Souza DC (2003) N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther 99: 79-94
65. Kuhn J, Lenartz D, Huff W, Lee S, Koulousakis A, Klosterkoetter J, Sturm V (2007) Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications? J Neurol Neurosurg Psychiatry 78: 1152-1153
66. Kuhn J, Gründler TO, Bauer R, Huff W, Fischer AG, Lenartz D, Maarouf M, Bührle C, Klosterkötter J, Ullsperger M, Sturm V (2011) Successful deep brain stimulation of the nucleus accumbens in severe alcohol dependence is associated with changed performance monitoring. Addict Biol 16: 620-623
67. Kuzmin A et al (2007) The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking. Neuropsychopharmacology 32: 902-910
68. Landgren S, Simms JA, Hyytiä P, Engel JA, Bartlett SE, Jerlhag E (2011) Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. Addict Biol [Epub ahead of print]
69. Lee MR, Hinton DJ, Wu J, Mishra PK, Port JD, Macura SI, Choi DS (2011) Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1. Neurosci Lett 490: 90-95
70. Leeman RF, Heilig M, Cunningham CL, Stephens DN, Duka T, O'Malley SS (2010) Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypes. Addict Biol 15: 109-124
71. Leggio L, Addolorato G (2010) Pharmacotherapy of alcohol dependence: past, present and future research. Curr Pharm Des 16: 2074-2075
72. Lovinger DM, White G, Weight FF (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243: 1721-1724
73. Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B, Mantero-Atienza E (1994) A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp Res 18: 1162-1167
74. Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB (1999) A double-blind, placebocontrolled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 56: 719-724
75. Mattick RP, Breen C, Kimber J, Davoli M (2009) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. Jul 8 (3): CD002209
76. Milton AL, Schramm MJ, Wawrzynski JR, Gore F, Oikonomou-Mpegeti F, Wang NQ, Samuel D, Economidou D, Everitt BJ (2012) Antagonism at NMDA receptors, but not β-adrenergic receptors, disrupts the reconsolidation of pavlovian conditioned approach and instrumental transfer for ethanol-associated conditioned stimuli. Psychopharmacology (Berl) 219: 751-761
77. Molander A, Söderpalm B (2005) Accumbal strychnine-sensitive glycine receptors: an access point for ethanol to the brain reward system. Alcohol Clin Exp Res 29: 27-37
78. Molander A, Lidö HH, Löf E, Ericson M, Söderpalm B (2007) The glycine reuptake inhibitor Org 25935 decreases ethanol intake and preference in male wistar rats. Alcohol Alcohol 42: 11-18
79. Molander A, Vengeliene V, Heilig M, Wurst W, Deussing JM, Spanagel R (2012) Brain-Specific Inactivation of the Crhr1 Gene Inhibits Post-Dependent and Stress-Induced Alcohol Intake, but Does Not Affect Relapse-Like Drinking. Neuropsychopharmacology 37: 1047-1056
80. Mucha RF, Herz A (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berl) 86: 274-280
81. Müller UJ, Sturm V, Voges J, Heinze HJ, Galazky I, Heldmann M, Scheich H, Bogerts B (2009) Successful treatment of chronic resistant alcoholism by deep brain stimulation of nucleus accumbens: first experience with three cases. Pharmacopsychiatry 42: 288-291
82. Nelson EC, Agrawal A, Pergadia ML, Wang JC, Whitfield JB, Saccone FS, Kern J, Grant JD, Schrage AJ, Rice JP, Montgomery GW, Heath AC, Goate AM, Martin NG, Madden PA (2010) H2 haplotype at chromosome 17q21. 31 protects against childhood sexual abuseassociated risk for alcohol consumption and dependence. Addict Biol 15: 1-11
83. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28: 1546-1552
84. Pawlak CR, Sanchis-Segura C, Soewarto D, Wagner S, Hrabé de Angelis M, Spanagel R (2008) A phenotype-driven ENU mutagenesis screen for the identification of dominant mutations involved in alcohol consumption. Mamm Genome 19: 77-84
85. Peng X, Neumeyer JL (2007) Kappa receptor bivalent ligands. Curr Top Med Chem 7: 363-373
86. Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233: 774-776
87. Pichini S, Farré M, Abanades S, Pacifici R, Zuccaro P, Langohr K, de la Torre R (2010) Immunomodulating properties of gamma-hydroxybutyrate (GHB), flunitrazepam and ethanol in 'club drugs' users. Addict Biol 15: 336-345
88. Rammes G, Schierloch A (2006) Neramexane (merz pharmaceuticals/forest laboratories). IDrugs 9: 128-135
89. Rösner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M (2010) Acamprosate for alcohol dependence. Cochrane Database Syst Rev 9: CD004332
90. Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (2010) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 12: CD001867
91. Rossetti ZL, Carboni S (1995) Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur J Pharmacol 283: 177-183
92. Schiller D, Monfils MH, Raio CM, Johnson DC, Ledoux JE, Phelps EA (2010) Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 463: 49-53
93. Schmid B, Blomeyer D, Treutlein J, Zimmermann US, Buchmann AF, Schmidt MH, Esser G, Rietschel M, Banaschewski T, Schumann G, Laucht M (2010) Interacting effects of CRHR1 gene and stressful life events on drinking initiation and progression among 19-year-olds. Int J Neuropsychopharmacol 13: 703-714
94. 2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP. Neuropharmacology 55: 546-554
95. Schumann G, Frank J, Preuss U, Dahmen N, Laucht M, Rujescu D, Hinckers A, Depner M, Wellek S, Treutlein J, Szegedi A, Giegling I, Blomeyer D, Heinz A, Lathrop M, Soyka M, Spanagel R, Mann K (2008) Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risk drinking behaviour. Arch Gen Psychiatry 65: 826-838
96. Schumann G et al (2011) Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A 108: 7119-7124. Epub 2011 Apr 6. Erratum in: Proc Natl Acad Sci U S A (2011) 108: 9316
97. Shippenberg TS, Zapata A, Chefer VI (2007) Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 116: 306-321
98. Sillaber I, Rammes G, Zimmermann S, Mahal B, Zieglgänsberger W, Wurst W, Holsboer F, Spanagel R (2002) Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science 296: 931-933
99. Sofuoglu M, Sewell RA (2009) Norepinephrine and stimulant addiction. Addict Biol 14: 119-129
100. Sommer WH, Rimondini R, Hansson AC et al (2008) Upregulation of Voluntary Alcohol Intake, Behavioral Sensitivity to Stress, and Amygdala Crhr1 Expression Following a History of Dependence. Biol Psychiatry 63: 139-145
101. Spence J, Liang T, Foroud T, Lo D, Carr L (2005) Expression profiling and QTL analysis: a powerful complementary strategy in drug abuse research. Addict Biol 10: 47-51
102. Spanagel R (2009) Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev 89: 649-705
103. Spanagel R, Hölter SM (1999) Long-term alcohol self-administration with repeated alcohol deprivation phases: An animal model of alcoholism? Alcohol Alcohol 34: 231-243
104. Spanagel R, Mann K (2005) Drugs for relapse prevention of alcoholism. Milestones in Drug Therapy. Birkhäuser, Basel
105. Spanagel R, Kiefer F (2008) Drugs for Relapse Prevention of Alcoholism-10 Years of Progress. Trends Pharmacol Sci 29: 109-115
106. Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A 89: 2046-2050
107. Spanagel R, Almeida OF, Shippenberg TS (1994) Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. Eur J Pharmacol 264: 157-162
108. Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC, Lascorz J, Depner M, Holzberg D, Soyka M, Schreiber S, Matsuda F, Lathrop M, Schumann G, Albrecht U (2005) The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 11: 35-42
109. Spanagel R, Bartsch D, Brors B, Dahmen N, Deussing J, Eils R, Ende G, Gallinat J, Gebicke-Haerter P, Heinz A, Kiefer F, Jager W, Mann K, Matthaus F, Nothen M, Rietschel M, Sartorius A, Schutz G, Sommer WH, Sprengel R, Walter H, Wichmann E, Wienker T, Wurst W, Zimmer A (2010) An integrated genome research network for studying the genetics of alcohol addiction. Addict Biol 15: 369-379
110. Sturgess JE, George TP, Kennedy JL, Heinz A, Müller DJ (2011) Pharmacogenetics of alcohol, nicotine and drug addiction treatments. Addict Biol 16: 357-376
111. Taqi MM, Bazov I, Watanabe H, Sheedy D, Harper C, Alkass K, Druid H, Wentzel P, Nyberg F, Yakovleva T, Bakalkin G (2011) Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics. Addict Biol 16: 499-509
112. Treutlein J, Kissling C, Frank J, Wiemann S, Dong L, Depner M, Saam C, Lascorz J, Soyka M, Preuss UW, Rujescu D, Skowronek MH, Rietschel M, Spanagel R, Heinz A, Laucht M, Mann K, Schumann G (2006) Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry 11: 594-602
113. Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, Zill P, Maier W, Moessner R, Gaebel W, Dahmen N, Fehr C, Scherbaum N, Steffens M, Ludwig KU, Frank J, Wichmann HE, Schreiber S, Dragano N, Sommer WH, Leonardi-Essmann F, Lourdusamy A, Gebicke-Haerter P, Wienker TF, Sullivan PF, Nöthen MM, Kiefer F, Spanagel R, Mann K, Rietschel M (2009) Genome-wide association study of alcohol dependence. Arch Gen Psychiatry 66: 773-784
114. Tsai GC, Coyle JT (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Ann Rev Med 49: 173-184
115. Tsai G, Gastfriend DR, Coyle JT (1995) The glutamatergic basis of human alcoholism. Am J Psychiatry 152: 332-340
116. Umhau JC, Momenan R, Schwandt ML, Singley E, Lifshitz M, Doty L, Adams LJ, Vengeliene V, Spanagel R, George DT, Hommer D, Heilig M (2010) Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study. Arch Gen Psychiatry 67: 1069-1077
117. Vengeliene V, Bachteler D, Danysz W, Spanagel R (2005) The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect. Neuropharmacology 48: 822-829
118. Vengeliene V, Leonardi-Essmann F, Perreau-Lenz S, Gebicke-Haerter P, Drescher K, Gross G, Spanagel R (2006) The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J 20: 2223-2233
119. Vengeliene V, Kiefer F, Spanagel R (2008) D-cycloserine facilitates extinction of conditioned alcohol-seeking behaviour in rats. Alcohol Alcohol 43: 626-629
120. Vengeliene V, Celerier E, Chaskiel L, Penzo F, Spanagel R (2009) Compulsive drug and food taking behaviour in rodents. Addict Biol 14: 384-396
121. Vengeliene V, Leonardi-Essmann F, Sommer WH, Marston HM, Spanagel R (2010) Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats. Biol Psychiatry 68: 704-711
122. Vollstädt-Klein S, Loeber S, Kirsch M, Bach P, Richter A, Bühler M, von der Goltz C, Hermann D, Mann K, Kiefer F (2011) Effects of cue-exposure treatment on neural cue reactivity in alcohol dependence: a randomized trial. Biol Psychiatry 69: 1060-1066
123. von der Goltz C, Vengeliene V, Bilbao A, Perreau-Lenz S, Pawlak CR, Kiefer F, Spanagel R (2009) Cue-induced alcohol-seeking behaviour is reduced by disrupting the reconsolidation of alcohol-related memories. Psychopharmacology 20: 389-397
124. Walker BM, Koob GF (2008) Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33: 643-652
125. Walker BM, Zorrilla EP, Koob GF (2011) Systemic j-opioid receptor antagonism by norbinaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict Biol 16: 116-119
126. Wee S, Koob GF (2010) The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology 210: 121-135
127. Williams TJ, LaForge KS, Gordon D, Bart G, Kellogg S, Ott J, Kreek MJ (2007) Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence. Addict Biol 12: 496-502
128. Xuei X, Dick D, Flury-Wetherill L, Tian HJ, Agrawal A, Bierut L, Goate A, Bucholz K, Schuckit M, Nurnberger J Jr, Tischfield J, Kuperman S, Porjesz B, Begleiter H, Foroud T, Edenberg HJ (2006) Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry 11: 1016-1024